Lv1
96 积分 2025-10-20 加入
Sintilimab and lenvatinib plus hepatic arterial infusion chemotherapy and embolization as conversion therapy for uHCC: A phase 2 trial
1个月前
已完结
Pemigatinib for Unresectable or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor-2 Rearrangement: Results From the Phase 3 FIGHT-302 Trial
2个月前
已关闭
Liver Tumor Screening and Diagnosis in CT with Pixel-Lesion-Patient Network
4个月前
已完结
Nivolumab plus ipilimumab for potentially resectable hepatocellular carcinoma: Long-term efficacy and biomarker exploration
4个月前
已完结
An in silico investigation: Can melatonin serve as an adjuvant in NR1D1-linked chronotherapy for amyotrophic lateral sclerosis?
4个月前
已完结
PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods
4个月前
已完结
Developing clinical prediction models: a step-by-step guide
4个月前
已完结
CT-Based Radiomics Models with External Validation for Prediction of Recurrence and Disease-Specific Mortality After Radical Surgery of Colorectal Liver Metastases
5个月前
已完结
Spatial immune scoring system predicts hepatocellular carcinoma recurrence
5个月前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
5个月前
已完结
皖公网安备34019202002308
